Upstate Active Clinical Trials Seeking Participants
Study title
The T1D Exchange Type 1 Diabetes Network Ancillary Study: Residual C-Peptide in Patients with Type 1 Diabetes
IRB number
292512
What is the purpose of the study?
The primary purpose is to learn how often patients with type 1 diabetes still make some of their own insulin (as measured by C-Peptide in the blood) and to evaluate the relationship between residual C-Peptide and some characteristics such as glycemic control, less hypoglycemia and fewer complications
Who is eligible?
Patients must:
1) Be participating in the T1D Exchange through the Joslin Diabetes Center at Upstate Medical University
2) Have been diagnosed with type 1 diabetes between ages of 6 months to 45 years.
3) Have diagnosis of type 1 diabetes for at least 3 years.
What is involved if I participate?
- How long is the study?
1 to 3 visits over a 12 month period - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
Blood samples will be collected at Visit 1 (Baseline) and some patients will be asked to return to the clinic for Mixed Meal Tolerance Tests (MMTT). The MMTT involves drinking liquid meal (such as Boost) and having blood samples drawn through an IV in the arm at specified times over a 2 hour period.
Who is the doctor administering the study?
Ruth Weinstock, MD, PhD
Where will the study take place?
Clinical Research Unit, IHP
Over what time period is the study scheduled to run?
February 2012 until enrollment is met (50 patients at our site and 1,000 patient across all sites)
Who can I contact for more information?
- Name: Jane Bulger
- Phone: 315-464-9008
- Email: bulgerj@upstate.edu
- Fax: 315-464-9076
Other information:
Information about the patient will be collected such as medications, family history of type 1 or type 2 diabetes, or other autoimmune diseases, and other information related to their type 1 diabetes.
If you are interested in this trial, please contact the study coordinator or investigator noted above.
